ID

37908

Description

A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01210768

Link

https://clinicaltrials.gov/show/NCT01210768

Keywords

Versions (1)
  1. 8/29/19 8/29/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

August 29, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01210768

English

Eligibility Breast Cancer NCT01210768

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed invasive, but non-inflammatory, breast adenocarcinoma with stage i or ii (if n0, t must be >1cm) disease
Description

Breast adenocarcinoma Invasive Noninflammatory | Disease TNM Breast tumor staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C0205281
UMLS CUI [1,3]
C0442743
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0474926
her2-negative on fluorescence in situ hybridization (fish) study
Description

HER2 Negative FISH

Data type

boolean

Alias
UMLS CUI [1,1]
C2348908
UMLS CUI [1,2]
C0162789
performance status of ecog 0, 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
female, age between 20 and 70 years
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
life expectancy of at least one year
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
ability to understand and willingness to sign a written informed consent document
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
her2 3+ over-expression on immunohistochemistry (ihc), or her2 amplification on fluorescence in situ hybridization (fish) study
Description

HER2 Protein Overexpression Immunohistochemistry | HER2 gene amplification FISH

Data type

boolean

Alias
UMLS CUI [1,1]
C1515560
UMLS CUI [1,2]
C0021044
UMLS CUI [2,1]
C1512127
UMLS CUI [2,2]
C0162789
previous or current systemic malignancy with the exception of curatively treated non-melanoma skin cancer or cervical carcinoma in situ, unless there has been a disease-free interval of at least 5 years
Description

Malignancy Systemic | Exception Curative treatment Skin carcinoma | Exception Curative treatment Carcinoma in situ of uterine cervix | Exception Disease Free Time Interval

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205373
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1273390
UMLS CUI [2,3]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1273390
UMLS CUI [3,3]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0012634
UMLS CUI [4,3]
C0332296
UMLS CUI [4,4]
C0872291
patients who have received prior chemotherapy
Description

Prior Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1514457
inadequate hematological function defined as absolute neutrophil count (anc)less than 1,500/mm3, and platelets less than 100,000/mm3
Description

Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
inadequate hepatic function defined as: serum bilirubin greater than 1.5 times the upper limit of normal range (uln) alanine aminotransferase (alt) or aspartate aminotransferase (ast) greater than 2.5 times the uln
Description

Liver function Inadequate | Serum bilirubin increased | Alanine aminotransferase increased | Aspartate aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0859062
UMLS CUI [3]
C0151905
UMLS CUI [4]
C0151904
inadequate renal function defined as serum creatinine greater than 1.5 times the uln
Description

Renal function Inadequate | Serum creatinine raised

Data type

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0700225
left ventricular ejection fraction (lvef) < 50% confirmed by multiple-gated acquisition (muga) scan or echocardiogram
Description

Left ventricular ejection fraction MUGA scan | Left ventricular ejection fraction Echocardiography

Data type

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0521317
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C0013516
concomitant illness that might be aggregated by chemotherapy or interfere study assessment. for examples, active, non- controlled infection (such as hepatitis b and hepatitis c, hiv, infectious tuberculosis) or other active, non-controlled disease such as congestive heart failure, ischemic heart disease, uncontrolled hypertension or arrhythmia, unstable diabetes mellitus, and active peptic ulcer
Description

Comorbidity Aggregation Due to Chemotherapy | Comorbidity Interferes with Study Assessment | Communicable Disease Uncontrolled | Hepatitis B | Hepatitis C | HIV Infection | Tuberculosis | Disease Uncontrolled | Congestive heart failure | Myocardial Ischemia | Uncontrolled hypertension | Cardiac Arrhythmia | Unstable diabetes mellitus | Peptic Ulcer

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0332621
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0392920
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2603343
UMLS CUI [2,4]
C1516048
UMLS CUI [3,1]
C0009450
UMLS CUI [3,2]
C0205318
UMLS CUI [4]
C0019163
UMLS CUI [5]
C0019196
UMLS CUI [6]
C0019693
UMLS CUI [7]
C0041296
UMLS CUI [8,1]
C0012634
UMLS CUI [8,2]
C0205318
UMLS CUI [9]
C0018802
UMLS CUI [10]
C0151744
UMLS CUI [11]
C1868885
UMLS CUI [12]
C0003811
UMLS CUI [13]
C0342302
UMLS CUI [14]
C0030920
patients who are presence of liver cirrhosis or are hbv/hcv carrier
Description

Liver Cirrhosis | Hepatitis B carrier | Hepatitis C carrier

Data type

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2]
C0262505
UMLS CUI [3]
C0400920
participation in another clinical trial with any investigational drug within 30 days prior to entry
Description

Study Subject Participation Status | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
pregnant or breast feeding women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
fertile women of child-bearing potential unless using a reliable and appropriate contraceptive method throughout the treatment period and for three months following cessation of treatment
Description

Childbearing Potential | Exception Use of Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1524063
UMLS CUI [2,3]
C0700589
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT01210768

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma Invasive Noninflammatory | Disease TNM Breast tumor staging
Item
histologically confirmed invasive, but non-inflammatory, breast adenocarcinoma with stage i or ii (if n0, t must be >1cm) disease
boolean
C0858252 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C0442743 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
HER2 Negative FISH
Item
her2-negative on fluorescence in situ hybridization (fish) study
boolean
C2348908 (UMLS CUI [1,1])
C0162789 (UMLS CUI [1,2])
ECOG performance status
Item
performance status of ecog 0, 1
boolean
C1520224 (UMLS CUI [1])
Gender | Age
Item
female, age between 20 and 70 years
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Life Expectancy
Item
life expectancy of at least one year
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
ability to understand and willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
HER2 Protein Overexpression Immunohistochemistry | HER2 gene amplification FISH
Item
her2 3+ over-expression on immunohistochemistry (ihc), or her2 amplification on fluorescence in situ hybridization (fish) study
boolean
C1515560 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C1512127 (UMLS CUI [2,1])
C0162789 (UMLS CUI [2,2])
Malignancy Systemic | Exception Curative treatment Skin carcinoma | Exception Curative treatment Carcinoma in situ of uterine cervix | Exception Disease Free Time Interval
Item
previous or current systemic malignancy with the exception of curatively treated non-melanoma skin cancer or cervical carcinoma in situ, unless there has been a disease-free interval of at least 5 years
boolean
C0006826 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0699893 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0851140 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0012634 (UMLS CUI [4,2])
C0332296 (UMLS CUI [4,3])
C0872291 (UMLS CUI [4,4])
Prior Chemotherapy
Item
patients who have received prior chemotherapy
boolean
C1514457 (UMLS CUI [1])
Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement
Item
inadequate hematological function defined as absolute neutrophil count (anc)less than 1,500/mm3, and platelets less than 100,000/mm3
boolean
C0221130 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Liver function Inadequate | Serum bilirubin increased | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
inadequate hepatic function defined as: serum bilirubin greater than 1.5 times the upper limit of normal range (uln) alanine aminotransferase (alt) or aspartate aminotransferase (ast) greater than 2.5 times the uln
boolean
C0232741 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0859062 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0151904 (UMLS CUI [4])
Renal function Inadequate | Serum creatinine raised
Item
inadequate renal function defined as serum creatinine greater than 1.5 times the uln
boolean
C0232804 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0700225 (UMLS CUI [2])
Left ventricular ejection fraction MUGA scan | Left ventricular ejection fraction Echocardiography
Item
left ventricular ejection fraction (lvef) < 50% confirmed by multiple-gated acquisition (muga) scan or echocardiogram
boolean
C0428772 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
Comorbidity Aggregation Due to Chemotherapy | Comorbidity Interferes with Study Assessment | Communicable Disease Uncontrolled | Hepatitis B | Hepatitis C | HIV Infection | Tuberculosis | Disease Uncontrolled | Congestive heart failure | Myocardial Ischemia | Uncontrolled hypertension | Cardiac Arrhythmia | Unstable diabetes mellitus | Peptic Ulcer
Item
concomitant illness that might be aggregated by chemotherapy or interfere study assessment. for examples, active, non- controlled infection (such as hepatitis b and hepatitis c, hiv, infectious tuberculosis) or other active, non-controlled disease such as congestive heart failure, ischemic heart disease, uncontrolled hypertension or arrhythmia, unstable diabetes mellitus, and active peptic ulcer
boolean
C0009488 (UMLS CUI [1,1])
C0332621 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,4])
C0009488 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2603343 (UMLS CUI [2,3])
C1516048 (UMLS CUI [2,4])
C0009450 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0019163 (UMLS CUI [4])
C0019196 (UMLS CUI [5])
C0019693 (UMLS CUI [6])
C0041296 (UMLS CUI [7])
C0012634 (UMLS CUI [8,1])
C0205318 (UMLS CUI [8,2])
C0018802 (UMLS CUI [9])
C0151744 (UMLS CUI [10])
C1868885 (UMLS CUI [11])
C0003811 (UMLS CUI [12])
C0342302 (UMLS CUI [13])
C0030920 (UMLS CUI [14])
Liver Cirrhosis | Hepatitis B carrier | Hepatitis C carrier
Item
patients who are presence of liver cirrhosis or are hbv/hcv carrier
boolean
C0023890 (UMLS CUI [1])
C0262505 (UMLS CUI [2])
C0400920 (UMLS CUI [3])
Study Subject Participation Status | Investigational New Drugs
Item
participation in another clinical trial with any investigational drug within 30 days prior to entry
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential | Exception Use of Contraceptive methods
Item
fertile women of child-bearing potential unless using a reliable and appropriate contraceptive method throughout the treatment period and for three months following cessation of treatment
boolean
C3831118 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial